This conference is designed for neurosurgeons, interventional neuroradiologists, neurologists, endovascular surgeons, residents, nurse practitioners, physician assistants and interventional technicians, and other health care professionals with a special interest in the field of management of neurovascular diseases and will be directly applicable to their daily practices.

OCIN provides the latest evidence-based data presented by leading physicians, nurses, and scientists that will affect the practice of neurovascular medicine. OCIN showcases the practical applications of current and emerging techniques and technologies and unparalleled diversity of live-case presentations from universities and medical centers from around the world. In the field of neurointervention, OCIN combines the hands-on and practical learning that fit in with physicians’ need to improve patient outcomes.

The overall goal of this activity is to improve competence and performance of our target audience by delivering cutting-edge educational content that showcases the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation will translate into improved patient care.

• Apply the results from important clinical trials and evidence-based medicine to guide management of patients with any type of neurovascular diseases such as cerebral aneurysms, cerebral/spinal arteriovenous malformations, acute ischemic stroke and arterial stenosis etc.
• Incorporate new interventional technologies and techniques into the care of patients with complex neurovascular disease
• Integrate advances in diagnostic evaluation and therapeutics to patients with carotid, vertebral, intracranial and spinal arterial disease
• Implement appropriate medical management in the care of patients undergoing diagnostic angiography and interventional therapies before, during, and after catheterization
• Improve safety and workflow in the angiography suite and share knowledge between physicians, technicians and nurses

The conference is sponsored by Shanghai Medical Association and co-organized by Wu Jieping Medical Foundation, China Anti-aging Promoting Association and Beijing Health Promotion Association. It is the policy of the Shanghai Medical Association to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations and therefore, does not compromise the scientific integrity of the educational activity.

This conference is partially funded through educational grants from industry partnership. Shanghai Medical Association ensures that the program is of educational nature and meets the needs of the target audience. To support this endeavor, the directors and co-directors of OCIN set up organizational and scientific committees to assist in the development and oversight of educational content for live cases, e-poster sessions, practical workshops (learning labs), and scientific lectures. These sessions are developed free of influence from industry partnership.